New pan-coronavirus vaccine passes key experiments, demonstrates protection

In laboratory and primate tests, a new pan-coronavirus vaccine developed by the Duke Human Vaccine Institute (DHVI) has demonstrated wide protection against SARS-CoV-2 viruses and variants, including omicron BA.5.

source https://medicalxpress.com/news/2022-10-pan-coronavirus-vaccine-key.html